From: The multifaceted therapeutic value of targeting steroid receptor coactivator-1 in tumorigenesis
Tissue | Collaborator | Regulated genes | Transcriptional potential | Ref |
---|---|---|---|---|
Breast | SRC-3 | — | Interacting with ER to regulate the core genes of breast cancer progression | |
Cyclin D1 | — | Cyclin D1 serves as a bridging factor between ER and SRC-1 | [60] | |
Ets2 | c-Myc, MMP9, HER2, CSF-1 | Interacting with Ets2 to upregulate target gene expression | ||
HOXC11 | S100beta | Collaborate with HOXC11 to promote S100beta expression | [63] | |
— | ADAM22 | Promoting steroid resistance by upregulating ADAM22 expression | [62] | |
Methylation factor complex | NR2F2, NTRK2, SETBP1, CTDP1, POU3F2 | Promoting endocrine resistance through an epigenetics reprogramming pathway | [64] | |
STAT1 | SMAD2, ASCL1, NFIA, E2F7 | Binding with STAT1 to promote its transcriptional activity | [65] | |
Ets1/2 | HER2 | Ets1/2 upregulates HER2 expression by recruiting SRC-1 | [67]. | |
c-Fos | CSF-1 | SRC-1 and c-Fos can be recruited to the functional AP-1 site in the CSF-1 promoter | [71] | |
c-Fos, HIF1α | VEGFa | Combining and recruiting the AP-1 site or HIF1α-binding element of VEGFa promoter | [72] | |
PEA3 | Twist, N-cadherin, vimentin | Collaborating with PEA3 to promote Twist expression to regulate target genes | [73] | |
AP-1 | ITGA5 | Collaborating with AP-1 to promote transcriptional activity of ITGA5 | [74] | |
STAT3 | Leptin mediated genes | Interacting with the STAT3 activation domain to enhance its signal transduction | [75]. | |
Prostate Cancer | AR, Androgen, IL-6, MAPK | AR-regulated genes | Enhancing the transactivation of AR | |
AR | PSA | Promoting the proliferation of prostate cancer cells by regulating PSA | ||
RORγ | AR-regulated genes | Be recruited to AR-ROR response elements by RORγ | [82] | |
Endometrial cancer | — | Mig-6 | SRC-1 is reduced in endometrial cancer tissue | |
Ovarian cancer | ERα, Estrogens | c-Myc | c-Myc is downregulated in SRC-1-deficient cells | [99] |
Meningioma | Progesterone, PR | PR-regulated genes | SRC-1 is expressed in the tissues of meningioma patients | [88] |
Astrocytoma | Progesterone, PR | VEGF | VEGF downregulated in SRC-1 deficient cells | |
Estradiol, ERα | — | Promoting estradiol induced astrocytoma cell growth | [92] | |
Glioblastoma | bFGF, PEA3 | VEGF, MMP9 | Enhancing bFGF or PEA3 mediated angiogenesis | [93] |
XIST/mi-152 | KLF4 | Promoting KLF4 expression and cell glioma of glioblastoma | [94] | |
Liver cancer | β-catenin | c-Myc, PCNA | Interacting with β-catenin directly to enhance Wnt/β-catenin signaling | |
miR-105-1 | — | miR-105-1 negatively regulates the mRNA level of SRC-1 | [85] | |
Colorectal cancer | miR-4443 | — | miR-4443 negatively regulates the mRNA level of SRC-1 | [86] |
GLI2 | cyclin D1, Bcl-2, Slug, N-cadherin, Vimentin | Enhancing Hedgehog signaling by directly binding to the zinc finger domain of GLI2 | [16] | |
Melanoma | HOXC11 | S100beta | Collaborating with HOXC11 to promote S100beta expression | [100] |
Thyroid cancer | NF-κB | VEGFC | Combining with NF-κB to form a coactivating complex that directly promotes VEGFC transcription |